Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06564987
PHASE1

Risk of Nerve Damage After Administration of Local Anesthesia

Sponsor: Cleveland Dental Institute

View on ClinicalTrials.gov

Summary

This research aims to evaluate of the risk of nerve damage following the administration of articaine 4% and lidocaine 2% for Inferior Alveolar nerve Block (IANB). A Randomized Controlled Clinical Trial will be conducted where the patient will be randomly assigned to one the two groups; articaine 4% and Lidocaine 2%. The type of LA will be concealed to the operator, investigators and assessors. The patients will be monitored for any aigns of nerve parathesia for 3 months after the procedure.

Official title: Risk of Nerve Damage After Administration of an Inferior Alveolar Nerve Block Using 4% Articaine Versus 2% Lidocaine

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2024-01-01

Completion Date

2025-03-31

Last Updated

2024-08-26

Healthy Volunteers

Yes

Interventions

DRUG

4% Articaine with 1:200,000 epinephrine

Inferior Alveolar Nerve Block with 4% articaine

DRUG

2% lidocaine with 1:100,000 epinephrine

Inferior Alveolar Nerve Block with 2% lidocaine

Locations (2)

Cleveland Dental Institute

Akron, Ohio, United States

Cleveland Dental Institute

Ashtabula, Ohio, United States